NOVARTIS
Lobbying client. Federal LDA filings.
- Source id
110215- General description
- Multinational biopharmaceutical company
- State
- DC
- Country
- US
- Principal place of business
- US
- Government-entity client
- false
- Effective date
- 2019-03-01
- Total spend (across 1 ingested filings)
- $90,000
Filings (1) — $90,000
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-20 | Q1 | 2026 | BROWNSTEIN HYATT FARBER SCHRECK, LLP | $90,000 |
Connected on the graph
60 typed relationships in the influence graph — 56 inbound, 4 outbound, grouped by type.
lobbied for (52)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Deema Tarazi | — | lda_lobbyist_client | |
| — | ← | Margaret Joseph | — | lda_lobbyist_client | |
| — | ← | Thomas Andrew Suter | — | lda_lobbyist_client | |
| — | ← | Brent Alan Del Monte | — | lda_lobbyist_client | |
| — | ← | Karina Lynch | — | lda_lobbyist_client | |
| — | ← | Michael Sorensen | — | lda_lobbyist_client | |
| — | ← | Emily H Murry | — | lda_lobbyist_client | |
| — | ← | Taylor Booth | — | lda_lobbyist_client | |
| — | ← | Margaret Martin | — | lda_lobbyist_client | |
| — | ← | Stephen Holland | — | lda_lobbyist_client | |
| — | ← | Peter Fise | — | lda_lobbyist_client | |
| — | ← | Esteban Bovo Jr | — | lda_lobbyist_client | |
| — | ← | Parick Braerton Carroll | — | lda_lobbyist_client | |
| — | ← | Kimberly Ellis | — | lda_lobbyist_client | |
| — | ← | Rich Thomas | — | lda_lobbyist_client | |
| — | ← | Robb Walton | — | lda_lobbyist_client | |
| — | ← | Daniel Farmer | — | lda_lobbyist_client | |
| — | ← | Carlos San Jose | — | lda_lobbyist_client | |
| — | ← | Joel D. Bailey | — | lda_lobbyist_client | |
| — | ← | Vincent Sarubbi Jr | — | lda_lobbyist_client | |
| — | ← | Courtney Piron | — | lda_lobbyist_client | |
| — | ← | Nancy Travis | — | lda_lobbyist_client | |
| — | ← | Richard Burr | — | lda_lobbyist_client | |
| — | ← | Sarah Durr | — | lda_lobbyist_client | |
| — | ← | Sloane Salzburg | — | lda_lobbyist_client | |
| — | ← | John Stone | — | lda_lobbyist_client | |
| — | ← | Raissa H Downs | — | lda_lobbyist_client | |
| — | ← | Chris Kelly | — | lda_lobbyist_client | |
| — | ← | Adam Steinmetz | — | lda_lobbyist_client | |
| — | ← | Andrew Usyk | — | lda_lobbyist_client | |
| — | ← | Courtney Lee-Ashley | — | lda_lobbyist_client | |
| — | ← | Remy Leigh Brim Mason | — | lda_lobbyist_client | |
| — | ← | Jennifer B Young | — | lda_lobbyist_client | |
| — | ← | Charlotte Spears Ivancic | — | lda_lobbyist_client | |
| — | ← | Zachary Pfister | — | lda_lobbyist_client | |
| — | ← | Peter Stehouwer | — | lda_lobbyist_client | |
| — | ← | Leo A Farber | — | lda_lobbyist_client | |
| — | ← | Pamela Smith | — | lda_lobbyist_client | |
| — | ← | Emily Felder | — | lda_lobbyist_client | |
| — | ← | Joseph Mcgowan | — | lda_lobbyist_client | |
| — | ← | Raghav Aggarwal | — | lda_lobbyist_client | |
| — | ← | Elizabeth T Murray | — | lda_lobbyist_client | |
| — | ← | Jeffrey Forbes | — | lda_lobbyist_client | |
| — | ← | Barrett Thornhill | — | lda_lobbyist_client | |
| — | ← | Derrick M White | — | lda_lobbyist_client | |
| — | ← | Kristina Dunklin | — | lda_lobbyist_client | |
| — | ← | Jeffrey Strunk | — | lda_lobbyist_client | |
| — | ← | Michael Alexander Williams | — | lda_lobbyist_client | |
| — | ← | Robert Blair | — | lda_lobbyist_client | |
| — | ← | Cynthia Brown | — | lda_lobbyist_client | |
| — | ← | Elizabeth Greer | — | lda_lobbyist_client | |
| — | ← | Michael Corcoran | — | lda_lobbyist_client |
lobbies on bill (4)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | → | Maintaining Investments in New Innovation Act HR 1672 · introduced 2025-02-27 · latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determ… | — | H.R. 1672 | lobbying_bill_mention |
| 2026-01-01 | → | EPIC Act of 2025 S 832 · introduced 2025-03-04 · latest action: Read twice and referred to the Committee on Finance. | — | S. 832 | lobbying_bill_mention |
| 2026-01-01 | → | Access to Breast Cancer Diagnosis Act of 2025 S 1500 · introduced 2025-04-28 · latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. | — | S. 1500 | lobbying_bill_mention |
| 2026-01-01 | → | Access to Breast Cancer Diagnosis Act of 2025 HR 3037 · introduced 2025-04-28 · latest action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determ… | — | H.R. 3037 | lobbying_bill_mention |
co acted on bill with (2)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | ← | Tillis, Thomas | — | s832-119 | lda_filing |
| 2026-01-01 | ← | Davis, Donald G. | — | hr1672-119 | lda_filing |
lobbies for (2)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | ← | FORBES-TATE | $50,000 | lda_filing | |
| 2025-01-01 | ← | CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS | — | lda_filing |